The Safety and Efficacy of the Repeated PRRT with [(90)Y]Y/[(177)Lu]Lu-DOTATATE in Patients with NET

PURPOSE: The peptide receptor radionuclide therapy (PRRT) is a treatment option for patients with disseminated, inoperable G1 and G2 neuroendocrine tumours (NETs). The study aims to evaluate the safety, efficacy, and progression-free survival (PFS) of patients after retreatment (R-PRRT) and re-retre...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Endocrinol
Prif Awduron: Zemczak, Anna, Gut, Paweł, Pawlak, Dariusz, Kołodziej, Maciej, Królicki, Leszek, Kos-Kudła, Beata, Ruchała, Marek, Kamiński, Grzegorz, Kunikowska, Jolanta
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Hindawi 2021
Pynciau:
Research Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7847334/
https://ncbi.nlm.nih.gov/pubmed/33552155
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6615511
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg